February 18, 2020

Allurion nets $34M to market its swallowable weight-loss balloon

Allurion is a previous MLSC awardee through the Center’s Accelerator Loan Program

Kudos to Natick, MA-based gastric weight-loss balloon manufacturer Allurion Technologies, which raised $34 million in new funding to boost its commercialization efforts and entry into the U.S. market, pending FDA approval.

Allurion, awarded a $750,000 Accelerator Loan from the MLSC, repaid the loan with interest in March 2017 after a successful funding round from private investors. Allurion’s repayment to the MLSC totaled $1,115,824. The Accelerator Loan Program’s design was to help early-stage companies through a critical stage of development and to leverage additional sources of capital to bring cutting-edge innovation to market.